Table 4.
Multivariate analysis of OS and CSS in the patients with r-NENs and hepatic metastases.
| Characteristics | P value | Overall survival | P value | Cancer-specific survival | ||||
|---|---|---|---|---|---|---|---|---|
| Hazard ratio | 95% CI | Hazard ratio | 95% CI | |||||
| Lower | Upper | Lower | Upper | |||||
| Age(yr) | ||||||||
| <50 | Reference | Reference | ||||||
| 50-69 | 0.089 | 1.482 | 0.942 | 2.331 | 0.169 | 1.382 | 0.872 | 2.189 |
| ≥70 | 0.161 | 1.537 | 0.842 | 2.806 | 0.357 | 1.338 | 0.720 | 2.484 |
| Race | ||||||||
| White | Reference | Reference | ||||||
| Black | 0.852 | 0.955 | 0.590 | 1.546 | 0.835 | 1.053 | 0.646 | 1.717 |
| Other | 0.003 | 0.390 | 0.211 | 0.722 | 0.009 | 0.435 | 0.234 | 0.809 |
| Grade | ||||||||
| G1 | Reference | Reference | ||||||
| G2 | 0.361 | 1.646 | 0.565 | 4.796 | 0.316 | 1.741 | 0.588 | 5.156 |
| G3 | ≤0.001 | 6.555 | 2.885 | 14.896 | ≤0.001 | 6.962 | 2.992 | 16.198 |
| G4 | 0.005 | 3.416 | 1.447 | 8.065 | 0.008 | 3.353 | 1.376 | 8.169 |
| Unknown | 0.027 | 2.568 | 1.112 | 5.930 | 0.021 | 2.743 | 1.163 | 6.466 |
| T stage | ||||||||
| T1 | Reference | Reference | ||||||
| T2 | 0.288 | 0.599 | 0.233 | 1.543 | 0.296 | 0.584 | 0.214 | 1.599 |
| T3 | 0.595 | 0.774 | 0.301 | 1.991 | 0.625 | 0.779 | 0.286 | 2.122 |
| T4 | 0.592 | 1.315 | 0.482 | 3.586 | 0.526 | 1.407 | 0.490 | 4.039 |
| Tx | 0.425 | 0.682 | 0.266 | 1.746 | 0.428 | 0.667 | 0.245 | 1.814 |
| N stage | ||||||||
| N0 | Reference | Reference | ||||||
| N1 | 0.057 | 1.526 | 0.987 | 2.360 | 0.088 | 1.477 | 0.943 | 2.315 |
| Nx | 0.029 | 1.942 | 1.069 | 3.526 | 0.027 | 2.010 | 1.085 | 3.726 |
| Surgery of the primary | ||||||||
| No surgery | Reference | Reference | ||||||
| Local | 0.002 | 0.224 | 0.087 | 0.575 | 0.002 | 0.205 | 0.075 | 0.564 |
| Radical | 0.001 | 0.292 | 0.138 | 0.615 | 0.002 | 0.308 | 0.144 | 0.659 |
| Chemotherapy | ||||||||
| Yes | Reference | Reference | ||||||
| No | 0.022 | 1.812 | 1.089 | 3.016 | 0.032 | 1.782 | 1.050 | 3.024 |